BLBD three-lens brief
Evidence-based stock research on BLBD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 18.1pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 18.1pp over 30 days.
- P/E of 7.4 — trading at a value multiple.
- Analyst mean target $89.13 — 44% above current (8 analysts).
- Negative free cash flow last quarterly (-$10.41M).
BLBD closed at $62.05 (-0.86%) as of 2026-09-11. Market cap: $1.97B. P/E (trailing) 7.4. Price is below the 50-day MA and above the 200-day MA. Positives: p/E of 7.4 — trading at a value multiple.; analyst mean target $89.13 — 44% above current (8 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 18.1pp over 30 days.. Last quarter: Revenue $517.16M, net income $185.25M, free cash flow -$10.41M.
Why three lenses on BLBD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLBDacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLBD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLBD brief"></iframe>